Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain

References

• Baron R, Binder AS, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807–819.
   PubMed Web of Science ®Google Scholar
• Attal N, Bouhassira D. Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? Pain. 2015;156 Suppl 1:S104–S114.
   Google Scholar
• Van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155:654–662.
   PubMed Web of Science ®Google Scholar
• Torrance N, Lawson KD, Afolabi E, et al. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter? Pain. 2014;155:1992–2004.
   Web of Science ®Google Scholar
• Finnerup N, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162–173.
   PubMed Web of Science ®Google Scholar
• Gilron I, Bailey JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double blind, randomised controlled crossover trial. Lancet. 2009;374:1252–1261.
   PubMed Web of Science ®Google Scholar
• Gilron I, Tu D, Holden RR, et al. Combination of morphine with nortriptyline for neuropathic pain. Pain. 2015;156:1440–1448.
   PubMed Web of Science ®Google Scholar
• Holbech JV, Bach FW, Finnerup NB, et al. Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial. Pain. 2015;156:958–966.
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Wilhelm S, Lledo A, et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The “Combo-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154:2616–2625.
   PubMed Web of Science ®Google Scholar
• Sawynok J. Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development. Eur J Pain. 2014;18:465–481.
   PubMed Web of Science ®Google Scholar
• EPC2001-07. A single-blind, multi-site assay to determine the skin sensitization potential of four (4) test products when applied to the skin of 200 healthy human subjects in a shared panel assay. Clinical Study Report. 54 p.
   Google Scholar
• EPC2001-10. A double-blind, placebo-controlled trial to examine the efficacy of topical amitriptyline, topical ketamine and a combination in the treatment of neuropathic pain. Clinical Study Report. 107 p.
   Google Scholar
• EPC2001-11. A multicentre, double-blind, randomized, placebo-controlled study of the efficacy and safety of 2 different doses of EpiCept-NP® topical cream (ketamine/amitriptyline combination) applied 2 times daily in the treatment of post-herpetic neuralgia. Clinical Study Report. 61 p.
   Google Scholar
• EPC2004-04. An open-label pharmacokinetic study in healthy volunteers to study EpiCeptTM-NP-1 (amitriptyline 4%/ketamine 2%) topical cream. Clinical Study Report. 59 p.
   Google Scholar
• EPC2006-01. A phase II, multicentre, double-blind, randomized, placebo-controlled study of the efficacy and safety of EpiCeptTM NP-1 topical cream (amitriptyline 4%/ketamine 2%) applied twice daily in patients with pain from diabetic peripheral neuropathy (DPN). Clinical Study Report. 97 p. [ClinicalTrials.gov NCT00476151]
   Google Scholar
• EPC2007-02. A phase II, double-blind, randomized, placebo-controlled non-inferiority trial of EpiCeptTM NP-1 topical cream (amitriptyline 4%/ketamine 2%) vs oral gabapentin in postherpetic neuralgia (PHN). 108 p. [ClinicalTrials.gov NCT00475904]
   Google Scholar
• Thompson DF, Brooks KG. Systematic review of topical amitriptyline for the treatment of neuropathic pain. J Clin Pharm Ther. 2015. doi:10.1111/jcpt.12297. [ePub].
   Web of Science ®Google Scholar
• Noppers I, Niesters M, Aarts L, et al. Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother. 2010;11:2417–2429.
   PubMed Web of Science ®Google Scholar
• Tawfic QA. A review of the use of ketamine in pain management. J Opioid Manage. 2013;9:379–388.
   PubMedGoogle Scholar
• Kopsky DJ, Keppel Hesselink JM, Bhaskar A, et al. Analgesic effects of topical ketamine. Minerva Anestesiol. 2015;81:440–449.
   PubMed Web of Science ®Google Scholar
• Sawynok J. Topical and peripheral ketamine as an analgesic. Anesth Analg. 2014;119:170–178.
   PubMed Web of Science ®Google Scholar
• Esser MJ, Sawynok J. Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects. Pain. 1999;80:643–653.
   PubMed Web of Science ®Google Scholar
• Garcia X, del Valle J, Escribano E, et al. Analgesic and antiallodynic effects of antidepressants after infiltration into the rat. Pharmacology. 2010;86:216–223.
   PubMed Web of Science ®Google Scholar
• Oatway M, Reid A, Sawynok J. Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat. Anesth Analg. 2003;97:168–173.
   PubMed Web of Science ®Google Scholar
• Sawynok J, Reid AR, Esser MJ. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain. 1999;80:45–55.
   PubMed Web of Science ®Google Scholar
• Sung B, Wang GK. Peripherally administered amitriptyline derivatives have differential anti-allodynic effects in a rat model of neuropathic pain. Neurosci Lett. 2004;357:115–118.
   PubMed Web of Science ®Google Scholar
• Ulugol A, Karadag HC, Tamer M, et al. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Neurosci Lett. 2002;328:129–132.
   PubMed Web of Science ®Google Scholar
• Davidson EM, Carlton SM. Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors. Brain Res. 1998;785:136–142.
   PubMed Web of Science ®Google Scholar
• Romero TRL, Duarte IDG. Involvement of ATP-sensitive K+ channels in the peripheral antinociceptive effect induced by ketamine. Vet Anaes Analg. 2013;40:419–424.
   PubMed Web of Science ®Google Scholar
• Romero TRL, Galdino GS, Silva GC, et al. Ketamine activates the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats. Anesth Analg. 2011;113:1254–1259.
   PubMed Web of Science ®Google Scholar
• Miller KE, Hoffman EM, Sutharshan M, et al. Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther. 2011;130:283–309.
   PubMed Web of Science ®Google Scholar
• Sawynok J, Reid AR. Peripheral interactions between dextromethorphan, ketamine and amitriptyline on formalin-evoked behaviors and paw edema in rats. Pain. 2003;102:179–186.
   PubMed Web of Science ®Google Scholar
• Von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron. 2012;73:638–652.
   PubMed Web of Science ®Google Scholar
• Micó JA, Ardid D, Berrocoso E, et al. Antidepressants and pain. Trends Pharmacol Sci. 2006;27:348–354.
   PubMed Web of Science ®Google Scholar
• Verdu B, Decosterd I, Buclin T, et al. Antidepressants for the treatment of chronic pain. Drugs. 2008;68:2611–2632.
   PubMed Web of Science ®Google Scholar
• O’Sullivan JB, Ryan KM, Curtin NM, et al. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol. 2009;12:687–699.
   PubMed Web of Science ®Google Scholar
• Sadeghi H, Hajhashemi V, Minaiyan M, et al. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats. Eur J Pharmacol. 2011;667:396–401.
   PubMed Web of Science ®Google Scholar
• De Kock M, Loix S, Lavand’homme P. Ketamine and peripheral inflammation. CNS Neurosci Ther. 2013;19:403–410.
   PubMed Web of Science ®Google Scholar
• Liu F-L, Chen T-L, Chen R-M. Mechanisms of ketamine-induced immunosuppression. Acta Anaesthesiol Taiwan. 2012;50:172–177.
   PubMedGoogle Scholar
• Persson J. Ketamine in pain management. CNS Neurosci Ther. 2013;19:396–402.
   PubMed Web of Science ®Google Scholar
• Esser MJ, Sawynok J. Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur J Pharmacol. 2000;399:131–139.
   PubMed Web of Science ®Google Scholar
• Orsulak PJ, Schildkraut JJ. Guidelines for therapeutic monitoring of tricyclic antidepressant plasma levels. Therap Drug Mon. 1979;1:199–208.
   PubMed Web of Science ®Google Scholar
• Dworkin RH, O’Conner AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3):S3–S14.
   PubMed Web of Science ®Google Scholar
• Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesthy. 1989;36:186–197.
   PubMed Web of Science ®Google Scholar
• Wallace MS, Ridgeway B, Leung A, et al. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia. J Clin Pharmacol. 2002;42:70–80.
   PubMed Web of Science ®Google Scholar
• Lynch ME, Clark AJ, Sawynok J. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain. 2003;19:323–328.
   PubMed Web of Science ®Google Scholar
• Lynch ME, Clark AJ, Sawynok J, et al. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes. A randomized, double-blind, placebo-controlled trial. Anesthesiology. 2005;103:140–146.
   PubMed Web of Science ®Google Scholar
• Lynch ME, Clark AJ, Sawynok J, et al. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain. 2005;6:644–649.
   PubMed Web of Science ®Google Scholar
• Manovsky T, Lynch ME, Clark AJ, et al. Pain catastrophizing predicts poor response to topical analgesics in patients with neuropathic pain. Pain Res Manage. 2012;17:10–14.
   PubMed Web of Science ®Google Scholar
• Poterucha TJ, Murphy SL, Rho RH, et al. Topical amitriptyline-ketamine for treatment of rectal, genital, and perineal pain and discomfort. Pain Physician. 2012;15:485–488.
   PubMed Web of Science ®Google Scholar
• Poterucha TJ, Weiss WT, Warndahl RA, et al. Topical amitriptyline combined with ketamine for the treatment of erythromelalgia: a retrospective study of 36 patients at Mayo Clinic. J Drugs Dermatol. 2013;12:308–310.
   PubMed Web of Science ®Google Scholar
• Poterucha TJ, Murphy SL, Sandroni P, et al. Topical amitriptyline combined with topical ketamine for the management of recalcitrant localized pruritus: a retrospective pilot study. J Am Acad Dermatol. 2013;69:320–321.
   PubMed Web of Science ®Google Scholar
• Barros GAM, Miot HA, Braz AM, et al. Topical (S)-ketamine for pain management of postherpetic neuralgia. An Bras Dermatol. 2012;87:504–505.
   PubMed Web of Science ®Google Scholar
• Ho KY, Huh BK, White WD, et al. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain. 2008;24:51–55.
   PubMed Web of Science ®Google Scholar
• Mahoney JM, Vardaxis V, Moore JL, et al. Topical ketamine cream in the treatment of painful diabetic neuropathy. A randomized, placebo-controlled, double-blind initial study. J Am Pod Med Assoc. 2012;102:178–183.
   PubMed Web of Science ®Google Scholar
• APL99-01. A double blind, placebo-controlled, crossover, pilot study to examine the efficacy of topical amitriptyline/ketamine versus topical ketamine, topical amitriptyline, and placebo in the treatment of neuropathic pain. Clinical Study Report. 49 p.
   Google Scholar
• Gewandter JS, Mohile SG, Heckler CE, et al. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors. Support Care Cancer. 2014;22:1807–1814.
   PubMed Web of Science ®Google Scholar
• Lockhart E. Topical combination of amitriptyline and ketamine for post herpetic neuralgia. J Pain. 2004;5:S82.
   Google Scholar
• Everton D, Bhagwat D, Damask M. A mulitcenter, double-blind, randomized, placebo-controlled study of the efficacy/safety of two doses of amitriptyline/ketamine topical cream in treating post-herpetic neuralgia (PHN). J Pain. 2007;8:S47
   Google Scholar
• Dworkin RH, Turk DC, Pierce-Sandner S, et al. Placebo and treatment group responses in post-herpetic neuralgia vs. painful diabetic neuropathy clinical trials in the REPORT database. Pain. 2010;150:12–16.
   PubMed Web of Science ®Google Scholar
• Pachman DR, Watson, JC, Lustberg MB, et al. Management options for established chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2014;22:2281–2295.
   PubMed Web of Science ®Google Scholar
• Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol. 2013;12:1084–1095.
   PubMed Web of Science ®Google Scholar
• Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin. 2009;25:1677–1687.
   PubMed Web of Science ®Google Scholar
• Mercadante S. Topical amitriptyline and ketamine for the treatment of neuropathic pain. Expert Rev Neurother. 2015;15:1249–1253.
   PubMed Web of Science ®Google Scholar